io102 Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 2 (1)

Interventional (1)

Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadcarcinoma

I am/have/hadcavity

I am/have/hadplatelet count

I am/have/hadsquamous cell carcinoma

I am/have/hadcarcinoma in situ of the cervix

I am/have/hadskin cancer

I am/have/hadmeasurable disease

I am/have/hadcarcinoma in situ of cervix

I am/have/hadsquamous cell carcinoma of the head and neck

I am/have/hadneutrophil count

I am/have/hadhead and neck carcinoma

I am/have/hadcancer

I am/have/hadmetastasis

I am/have/hadsecond malignancy

added new label for I am/have/had

more

I am looking for

I am looking forio102

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Activity and Safety of Peptide-based Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck.

The purpose of this project is to realize a randomized open-label study (EudraCT number: 2020-000120-19) to evaluate the safety and the anti-tumor activity of peptide(s)-based immunotherapy in an umbrella window pre-operative opportunity phase II study in patients with squamous cell carcinoma of the head and neck.

platelet count

cavity

carcinoma

squamous cell carcinoma

skin cancer

0 views
16 Feb, 2024
1 location

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2026 All rights reserved.